Search

Search Constraints

You searched for: Author/Creator Dejoie, Thomas

Search Results

1. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Issue 10192 (6th July 2019)

2. Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial. (19th June 2019)

3. Effectiveness of intraoperative use of dexmedetomidine in reducing the incidence of tachyarrhythmia after congenital cardiac surgery in neonates and infants: a doubly robust method estimation analysis. (2nd March 2023)

6. Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria. Issue 3 (4th March 2018)

7. Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies. Issue 7 (July 2022)

8. Long‐term outcome of monoclonal (type 1) cryoglobulinemia. Issue 2 (February 2014)

9. Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial. Issue 10 (October 2021)